DrugDashboards

Loratadine and Pseudoephedrine

loratadine and pseudoephedrine · LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1 · Tablet, Extended Release · Oral · Ohm Laboratories Inc.

NDC 51660-0491-69 · 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.5656 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Oct 2025Sep 2026$0.5656
11 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$16.97
#90 count
$50.91

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

5Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 5 active manufacturers+5

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for loratadine and pseudoephedrine (oral solid) in the next 90 days

sole-source market · price up 7% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA076557
TE code
Approval date
Sep 22, 2004
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of loratadine and pseudoephedrine (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
Ohm Laboratories Inc.LORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1Jul 15, 2026Sep 3, 2026
Amerisource BergenLORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPLORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1Jul 15, 2026Sep 2, 2026
Sportpharm LLCLORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1Jul 15, 2026Sep 2, 2026
Strategic Sourcing Services LlcLORATADINE 10 mg/1; PSEUDOEPHEDRINE SULFATE 240 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Loratadine and Pseudoephedrine — NDC 51660-0491-69," retrieved September 3, 2026, https://drugdashboards.com/drug/51660049169.

Free to cite with attribution — see how the data is put together.